[Treating hypertension only in case of high risk? Evidence-based therapy with cost control].
作者信息
Trenkwalder P
机构信息
Medizinische Klinik, Kreiskrankenhaus Starnberg.
出版信息
MMW Fortschr Med. 2001 Feb 15;143(7):45-6.
PMID:11268751
Abstract
摘要
相似文献
1
[Treating hypertension only in case of high risk? Evidence-based therapy with cost control].[仅在高危情况下治疗高血压？基于证据的成本控制疗法]
MMW Fortschr Med. 2001 Feb 15;143(7):45-6.
2
[New treatment strategies for the management of hypertension].[高血压管理的新治疗策略]
MMW Fortschr Med. 2009 Nov 12;151(46):33-6.
3
The value of antihypertensive drugs: a perspective on medical innovation.抗高血压药物的价值：医学创新视角
Health Aff (Millwood). 2007 Jan-Feb;26(1):97-110. doi: 10.1377/hlthaff.26.1.97.
4
[Treatment of hypertension. Between progress and cost control].[高血压的治疗。在进展与成本控制之间]
MMW Fortschr Med. 1999 Oct 21;141(42):46.
5
[Hypertension therapy--never without diuretics?].[高血压治疗——离不开利尿剂？]
MMW Fortschr Med. 2007 Nov 15;149(46):31-3.
6
Improving practice guidelines with patient-specific recommendations.通过针对患者的建议改进实践指南。
Ann Intern Med. 2011 May 3;154(9):638-9. doi: 10.7326/0003-4819-154-9-201105030-00010.
7
[Innovation or pseudo-innovation: that is the question].[创新还是伪创新：这就是问题所在]
Med Klin (Munich). 2006 Mar 15;101(3):257-62. doi: 10.1007/s00063-006-1034-8.
8
[Hypertension and stroke: new publications in 2005].[高血压与中风：2005年的新出版物]
MMW Fortschr Med. 2005 Nov 17;147(46):40-2, 44.
9
The cost-effectiveness of implementing a new guideline for cardiovascular risk management in primary care in the Netherlands.在荷兰初级医疗保健中实施心血管风险管理新指南的成本效益。
Eur J Cardiovasc Prev Rehabil. 2009 Jun;16(3):371-6. doi: 10.1097/HJR.0b013e328329497a.
10
[Real and assumed potential savings in antihypertensive treatment. Right out of the magician's hat].[抗高血压治疗中实际和假定的潜在节省。就像从魔术师帽子里变出来的一样]
Dtsch Med Wochenschr. 2003 Jul 11;128(28-29):1557-9. doi: 10.1055/s-2003-40387.
Zotero 插件